Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancerS G Taylor, M W Knuiman, L A Sleeper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cellsM R Albertini, D F Gibson, S P Robinson, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancerS G Taylor, M W Knuiman, L A Sleeper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cellsM R Albertini, D F Gibson, S P Robinson, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Pageof 14